Curing Diabetes
DRI Strategy
Site – Engineering a home for islets
What is Islet Transplantation?
Sustain – Ensuring islet cell survival
Supply – Creating more islets
Clinical Trials
Patient Stories
CELZ-201 Clinical Trial
Clinical Trial: Islets in Omentum
Clinical Trial: POSEIDON Study
Clinical Trial: Intraocular Islet Transplant
Our Research Progress
Global Partners
Living With Diabetes
What Is Diabetes
Warning Signs Of Diabetes
Types Of Diabetes
Type 1 Vs Type 2 Diabetes
Type 1 Diabetes
Type 1 Diabetes Causes
Type 1 Diabetes Symptoms
Is there a cure for type 1 diabetes?
Type 2 Diabetes
Diabetes Type 2 Treatment
Support for Parents
504
Diabetes news you can use
Managing Diabetes: Tips & Resources
Take a Class, Meet our Team
Aleida M Saenz APRN, FNP-BC, CDCES
Maddison Saalinger, MS, RD, LDN
How You Can Help
Giving
Give a Tribute Gift
Become a Monthly Donor
Gift Planning
Donor Advised Funds
Corporate Partners
Corporate Partner Blog
Our Events
Create a Fundraiser for Team DRI
Create an Event
Special Campaigns
#DRISnackChallenge
Vehicles for Charity
Generous Partners
New Leadership Council
Newsroom
Press Releases & News
Publications
Diabetes Stats
Media Coverage Archive
About Us
Diabetes Research Institute
DRI Faculty
Scientific Advisory Board
Diabetes Research Institute Foundation
National Board of Directors
Honorary Board & Former Chairmen
Regional Boards of Directors
DRI Foundation Staff
Financial Management
Contact Us
DONATE
RESEARCH PROGRESS
Home
5
Research Progress
5
2017 DRI Scientists Identify New Metabolic “Signature” as Potential Key Biomarker for Type 1 Diabetes Development
DRI Strategy
Clinical Trials
Our Research Progress
Global Partners
2017 DRI Scientists Identify New Metabolic “Signature” as Potential Key Biomarker for Type 1 Diabetes Development
Keep Up With Our Progress Toward A Cure & More
BE A DRI INSIDER - GET NEWS!
